Retinal Changes Linked to Cognitive Function in T1DM Patients
WEDNESDAY, Jan. 20, 2021 -- Abnormalities detected on noninvasive retinal imaging are associated with markers of cognitive dysfunction in older individuals with type 1 diabetes, according to a study published online Dec. 30 in the Journal of Clinical Endocrinology & Metabolism.
Ward Fickweiler, M.D., from the Joslin Diabetes Center in Boston, and colleagues conducted complete cognitive testing, optical coherence tomography (OCT), and OCT angiography (OCTA) on 129 participants with 50 or more years of type 1 diabetes.
The researchers found that decreased vessel density of the superficial retinal capillary plexus and deep retinal capillary plexus was associated with worse delayed memory and dominant hand psychomotor speed. Worse psychomotor speed in both nondominant and dominant hands was associated with thinning of the retinal outer nuclear layer. Delayed memory was associated with outer plexiform layer thickness.
"These findings suggest that noninvasive retinal imaging using OCT and OCTA may assist in estimating the risks for cognitive dysfunction in people with type 1 diabetes," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
WEDNESDAY, March 3, 2021 -- Women with type 1 diabetes (T1D) experience a shorter reproductive period than women without T1D, according to a study published online March 1 in...
TUESDAY, March 2, 2021 -- Provider teams outperform solo providers for management of three new-onset chronic diseases, while among solo providers, care management and outcome...
MONDAY, March 1, 2021 -- Diets with a high glycemic index are associated with an increased risk for cardiovascular disease and death, according to a study conducted on five...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.